Asia Pacific Equities Category Report

Published on by on October 15, 2009 | Updated March 15, 2012

Last modified: March 15, 2012

The Asia Pacific Equities ETFdb Category contains 25 ETFs with a total market capitalization of approximately $18.6 billion (as of March 15, 2012)

The following are the three largest ETFs in this ETFdb Category by market capitalization (as of March 15, 2012):

Ticker ETF Market Cap
EWY iShares MSCI South Korea Index Fund $3.47 billion
EPP iShares MSCI Pacific Ex-Japan Fund $3.42 billion
EWA iShares MSCI Australia Index Fund $2.70 billion

View all ETFs in this ETFdb Category

The Asia Pacific Equities ETFdb Category includes funds holding common equities listed on stock exchanges in Asia Pacific countries. Funds in this ETFdb Category include both ETFs that are diversified across multiple countries and ETFs offering exposure to a single nation, including:

Pro Membership Required to Continue Reading ETFdb Pro

To continue reading this article, you must be an ETFdb Pro member. Please login or begin your 14-day free trial to continue reading. There are several benefits to becoming an ETFdb Pro member today:
  • Register on ETFdbAccess to 50+ All-ETF model portfolios. Whether you're a long-term, buy-and-hold investor or a more active trader looking to establish a tactical position, our collection of ETFdb Portfolios has something for everyone.
  • ETFdb Realtime Ratings show you exactly where each fund stacks up next to the competition. Get objective, in-depth, custom research on every ETF.
  • Pro members have Unlimited Excel Download capabilities across the entire database; users can easily download more than 200 data filled paged and also export results to Microsoft Excel from every tool.
  • Get ETF Picks of the Month. For active investors seeking ETF investment ideas, our team analyzes technical and fundamental price drivers of more than 1,400 ETFs to identify both short and longer-term opportunities with a focus on absolute returns. Recommendations are actionable investment ideas that are poised for outperformance over the next week to 90 days.

Begin Your Free 14-Day Trial Now